What does Dr. Bram Ngo, Klinisch Bioloog do?

Dr. Bram Ngo, Klinisch Bioloog is a specialist medical practice in Hasselt. Private Limited, started on 30 April 2014, 1 establishment.

What is the address of Dr. Bram Ngo, Klinisch Bioloog?

The registered office of Dr. Bram Ngo, Klinisch Bioloog is located at Kerkhofstraat 110, 3500 Hasselt.

Is Dr. Bram Ngo, Klinisch Bioloog still active?

Yes. According to the CBE (1 October 2026) Dr. Bram Ngo, Klinisch Bioloog is active, legal situation “Normale toestand”, started on 30 April 2014.

Is Dr. Bram Ngo, Klinisch Bioloog registered on Peppol?

Yes, Dr. Bram Ngo, Klinisch Bioloog is registered on the Peppol network with ID 0208:0552552184.

What is the enterprise number of Dr. Bram Ngo, Klinisch Bioloog?

The enterprise number of Dr. Bram Ngo, Klinisch Bioloog is BE0552552184.

When was Dr. Bram Ngo, Klinisch Bioloog founded?

Dr. Bram Ngo, Klinisch Bioloog was founded on 30 April 2014.

Who are the directors of Dr. Bram Ngo, Klinisch Bioloog?

According to the 2025 annual accounts, the directors of Dr. Bram Ngo, Klinisch Bioloog are: Bram Ngo.

Is Dr. Bram Ngo, Klinisch Bioloog a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 April 2014; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Bram Ngo, Klinisch Bioloog make in 2025?

Dr. Bram Ngo, Klinisch Bioloog posted a profit after taxes of € 431,272 in financial year 2025.

What is the revenue of Dr. Bram Ngo, Klinisch Bioloog?

As a small company, Dr. Bram Ngo, Klinisch Bioloog is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 508,061.

Dr. Bram Ngo, Klinisch Bioloog (Private Limited)

Dossier Dr. Bram Ngo, Klinisch Bioloog, printed on 1 October 2026 from databakkes.be/en/0552552184/dr-bram-ngo-klinisch-bioloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Bram Ngo, Klinisch Bioloog from Hasselt, company number BE0552552184, closed financial year 2025 with a result of € 431,272 after tax. For that financial year Dr. Bram Ngo, Klinisch Bioloog recorded a gross margin of € 508,061 and equity of € 763,543. Compared with financial year 2024, the result moved from € 331,748 to € 431,272. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Growing

€ 763,543

▲ 96% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 431,272

▲ 30% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 130,067

▲ 194% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 56,404 paid out

13 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 15,663

▲ 112% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,377

▼ 14% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 28,942

▲ 205% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 431,206 Gross margin 2022: € 431,206 First fiscal year in the series	€ 398,979 Gross margin 2023: € 398,979 ▼ 7% vs 2022 (€ 431,206) Unfavourable step	€ 449,499 Gross margin 2024: € 449,499 ▲ 13% vs 2023 (€ 398,979) Favourable step	€ 508,061 Gross margin 2025: € 508,061 ▲ 13% vs 2024 (€ 449,499) Favourable step	▲ 13%
Profit after taxes	€ 324,054 Profit after taxes 2022: € 324,054 First fiscal year in the series	€ 275,030 Profit after taxes 2023: € 275,030 ▼ 15% vs 2022 (€ 324,054) Unfavourable step	€ 331,748 Profit after taxes 2024: € 331,748 ▲ 21% vs 2023 (€ 275,030) Favourable step	€ 431,272 Profit after taxes 2025: € 431,272 ▲ 30% vs 2024 (€ 331,748) Favourable step	▲ 30%
Equity	€ 294,514 Equity 2022: € 294,514 First fiscal year in the series	€ 388,675 Equity 2023: € 388,675 ▲ 32% vs 2022 (€ 294,514) Favourable step	€ 388,675 Equity 2024: € 388,675 Unchanged (€ 388,675) Unchanged	€ 763,543 Equity 2025: € 763,543 ▲ 96% vs 2024 (€ 388,675) Favourable step	▲ 96%
Total debts	€ 30,051 Total debts 2022: € 30,051 First fiscal year in the series	€ 99,443 Total debts 2023: € 99,443 ▲ 231% vs 2022 (€ 30,051) Unfavourable step	€ 370,727 Total debts 2024: € 370,727 ▲ 273% vs 2023 (€ 99,443) Unfavourable step	€ 110,734 Total debts 2025: € 110,734 ▼ 70% vs 2024 (€ 370,727) Favourable step	▼ 70%
Cash	€ 271,399 Cash 2022: € 271,399 First fiscal year in the series	€ 300,913 Cash 2023: € 300,913 ▲ 11% vs 2022 (€ 271,399) Favourable step	€ 44,201 Cash 2024: € 44,201 ▼ 85% vs 2023 (€ 300,913) Unfavourable step	€ 130,067 Cash 2025: € 130,067 ▲ 194% vs 2024 (€ 44,201) Favourable step	▲ 194%
Land & buildings	€ 568 Land & buildings 2022: € 568 First fiscal year in the series	€ 426 Land & buildings 2023: € 426 ▼ 25% vs 2022 (€ 568) Unchanged	€ 284 Land & buildings 2024: € 284 ▼ 33% vs 2023 (€ 426) Unchanged	€ 142 Land & buildings 2025: € 142 ▼ 50% vs 2024 (€ 284) Unchanged	▼ 50%
Retained profit	€ 275,914 Retained profit 2022: € 275,914 First fiscal year in the series	€ 277,075 Retained profit 2023: € 277,075 Unchanged (€ 275,914) Favourable step	€ 277,075 Retained profit 2024: € 277,075 Unchanged (€ 277,075) Unchanged	€ 651,943 Retained profit 2025: € 651,943 ▲ 135% vs 2024 (€ 277,075) Favourable step	▲ 135%
Dividend	€ 278,530 Dividend 2022: € 278,530 First fiscal year in the series	€ 273,869 Dividend 2023: € 273,869 ▼ 2% vs 2022 (€ 278,530) Unchanged	€ 331,748 Dividend 2024: € 331,748 ▲ 21% vs 2023 (€ 273,869) Unchanged	€ 56,404 Dividend 2025: € 56,404 ▼ 83% vs 2024 (€ 331,748) Unchanged	▼ 83%
Balance sheet total	€ 324,564 Balance sheet total 2022: € 324,564 First fiscal year in the series	€ 488,118 Balance sheet total 2023: € 488,118 ▲ 50% vs 2022 (€ 324,564) Unchanged	€ 759,401 Balance sheet total 2024: € 759,401 ▲ 56% vs 2023 (€ 488,118) Unchanged	€ 874,277 Balance sheet total 2025: € 874,277 ▲ 15% vs 2024 (€ 759,401) Unchanged	▲ 15%

Key figures of Dr. Bram Ngo, Klinisch Bioloog, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Bram Ngo, Klinisch Bioloog?

What happened at Dr. Bram Ngo, Klinisch Bioloog in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: profit of € 431,272 (▲ 30% vs 2024). Source: NBB ↗
May 21, 2014 New establishment in Tongeren-Borgloon. KBO
Apr 30, 2014 Start of the company according to the CBE. KBO

In short

From € 324,054 profit in 2022 to € 431,272 profit in 2025.

Paid € 486,287 in corporate taxes since 2022.

Best year ever: 2025, with € 431,272 profit.

Paid out € 940,551 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Bram Ngo, Klinisch Bioloog? We notify you, reason included.

Follow Dr. Bram Ngo, Klinisch Bioloog

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Bram Ngo

Dr. Bram Ngo, Klinisch Bioloog

Behind Dr. Bram Ngo, Klinisch Bioloog is Bram Ngo.

See the full network in the app

Directors

According to the 2025 annual accounts

Bram Ngo

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Kerkhofstraat 110

3500 Hasselt

2.230.647.830

Hazelereik 51

3700 Tongeren-Borgloon

Active since 21 May 2014

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

MONGO

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0552.552.184
VAT number: BE 0552.552.184
Registered office: Kerkhofstraat 110, 3500 Hasselt
Names & denominations: Dr. Bram Ngo, Klinisch Bioloog
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 30 April 2014
Peppol: Active · Active since 24 Nov 2023
Contact: 0473283904
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗